«üOmicron¹H¯f¬r¶i¤Æ¸`«µ ¿½³ÇùÚ¡G©Î´¿¶Ç°Êª«¦A¶Ç¦^¤H
¡i©ú³ø±M°T¡j·s«a¯f¬rOmicronÅܲ§¯f¬r®è¦bS³J¥Õ¤W¥X²{¦h¹F32ÓÅܲ§¡A²z¤jÂåÀø¬ì§Þ¤Î¸ê°T¾Ç¨t°Æ±Ð±Â¿½³ÇùÚªí¥Ü¡A¸ÓÅܺعH¤Ï¯f¬r¶i¤Æ¸`«µ¡A¦³¥i¯à¬O¯f¬r¶Çµ¹°Êª««á¦A¶Ç¦^µ¹¤HÃþ¡A¤~¥X²{OmicronÅܺءC
¿½³ÇùÚ¬Q¤é¦b°Ó¥x¡m¦b´¸®Ôªº¤@¤Ñ¥Xµo¡nªí¥Ü¡A¥Ñ2019¦~¦Ü¤µ¡A·s«¬«aª¬¯f¬r¤w¦³«Üéwªºµ²ºc¡A¥§¡¨C¤ë²Ö¿n1.8Ó°ò¦]¬ðÅÜ¡A¦ýOmicron¬ðµM¦h¤F«Ü¦h¬ðÅÜ¡A¶i«×³t«×¸ûDelta§Ö«Ü¦h¡A¹H¤Ï¯f¬r¶i¤Æ¸`«µ¡A¦ôp¥i¯à¬O¯f¬r¶Ç¤Fµ¹°Êª«¡A¦b·s±J¥D¨¤Wn«·s¾AÀ³¡A²£¥Í¤j¶qÅܲ§¡A¦A¶Ç¦^µ¹¤HÃþ¡C
BioNTech¡G¤w±Ò½Õ¾ã°t¤è«e´Á¤u§@
BioNTechÃļtµoÁn©ú¡AºÙ¤w±Ò°Ê¤F¹ïOmicronÅܲ§®è¤Î¬ÛÃö¬Ì]°t¤è½Õ¾ã¥i¯à©Êªº¬ã¨s¡A¤W©P¤w±Ò°Ê½Õ¾ã¬Ì]°t¤èªº«e´Á¤u§@¡A¤Î¬O§_»Ýn¬ãµo¬Ì]·s°t¤èªºµû¦ô¡A¤@¥¹ÃÒ¹êOmicronÅܲ§®è¦s¦b§K¬Ì°k¶hªº¼ç¤O¡A¥B¦³¦b¥þ²yÂX´²ªºÁͶաA¤w°µ¦n·Ç³Æ¥i¦b6©P¤º½Õ¾ã¥Ø«e¬ãµoªºmRNA¬Ì]¡A¨Ã¯à¦b100¤Ñ¤º¶}©l§å¶q¥æ¥I¡C
¥t¥~¡A¥»´ä¬Q¼W6©v¿é¤JӮסA°£¤F¤@¦W9·³¤kµ£©M¤@¦W1·³¨kµ£¡A¨ä¥L¤H³£¤w¥´¬Ì]¡A6¤H·í¤¤¦³4¤HÅç¥XL452RÅܲ§¯f¬r®è¡A¨S¦³¤HÅç¥XOmicron©Ò±aªºN501YÅܲ§¡C
¦¹¥~¡A^°ê¯èªÅ¦b¹L¥h¨âÓ©P¤»§¡¦³¤@¦W¾÷²Õ¤Hû¦b´ä¯f¬rÀË´ú§e¶§©Ê¡A¦P¾÷¨ä¥L¾÷²Õ¤Hû¶·Àˬ̡A^¯è¤W©P¤»ªí¥Ü¨M©w¼È°±¸©¹»´ä¡C^¯è¬Q¦^ÂÐ¥»³øªí¥Ü¡A¥¿¦b¤£Â_¼fµø©¹ªð»´äªºÀç¹B¡A¥Ø«e¤w¨ú®ø¯è¯Zª½¦Ü12¤ë4¤é¡C
(·s«a¬Ì±¡)